Tenderwize
Back to tender search

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tacrolimus (ATC-Code: L04AD02).

AOK Niedersachsen. Die Gesundheitskasse.Hannover, GermanyNot disclosed712 days leftopen
Sign up to save
40

Opportunity Score

Confidence: 40%

Complexity: low

712 days

Deadline

supplies

Contract

Framework

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Moderate opportunity

Non-exclusive discount agreement (Rabattvertrag) for Tacrolimus (ATC L04AD02) under an open-house model, allowing any eligible pharmaceutical company to join without competitive selection. The contract runs from 01.08.2026 to 31.07.2028, with the possibility to replace these agreements with exclusive contracts at any time. This notice is not a public procurement procedure but is published for transparency.

Strengths

Open procedure

Low complexity

712 days left

Risks

No procurement documents available

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in §4 Abs. 18 AMG regarding the offered medicinal products
  • Must have seat in Germany, EU, or EEA (§9 Abs. 2 Satz 1 AMG)
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs for the respective products

Buyer

Name

AOK Niedersachsen. Die Gesundheitskasse.

Location

Hannover, DEU

Identifier

AOK- Niedersachsen. Die Gesundheitskasse

Lots (1)

#LOT-0000Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tacrolimus (ATC-Code: L04AD02) innerhalb des Zeitraumes vom 01.08.2026 bis zum 31.07.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

Open-house discount agreement for Tacrolimus, non-exclusive, with uniform conditions. All interested pharmaceutical entrepreneurs can join. The contract may be terminated early if exclusive contracts are awarded.

33600000DEU

Procurement Details

Publication

14 Jun 2026

Deadline

27 May 2028, 11:00

Procedure

open

Contract

supplies

Language

DEU

Publication #

408619-2026

Classification

Pharmaceutical products

Performance: Germany

Pharmaceutical products Tender in Germany | TED 408619-2026